Tag: hepatocellular carcinoma

ASTRO 2022 abstracts
November 4, 2022/Radiation Oncology

Top Research from ASTRO 2022

Key abstracts highlight advances in treating locally advanced and refractory disease

22-DDI-2730958-Salivary-Biomarkers-identifying-Liver-Cancer-pilot-study-650×450-1

Salivary miRNAs Show Potential as Noninvasive Biomarkers of Hepatocellular Carcinoma

Novel study uses machine learning to create accurate predictive model for detection

16-DDI-160-LiverTumorClinic-CQD-650×450
October 8, 2020/Tumor Oncology

FDA Approves New Treatment Regime for Advanced Liver Cancer

IMbrave-150 changes standard of care

19-CNR-4143 650×450-Liver
February 28, 2020/Radiation Oncology

Case Report: Combination Radiotherapy for Mixed Liver Tumor

Treating a challenging cancer with novel use of radioembolization and SBRT

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

statins_650x450
October 28, 2019/Cancer

Statins Reduce Risk of Hepatocellular Carcinoma

Study finds a 43% lower risk of HCC in statin users

hepatocellular-carcinoma
April 25, 2018/Research

Pretransplant Locoregional Therapy for Advanced HCC May Optimize Long-Term Survival

Response to locoregional therapy helps predict tumor behavior and transplant success

17-DDI-3851-Complex-Liver-CQD-Hero
August 16, 2017/Cancer

Complex Liver Resection As a Curative Surgery for HCC: A Case Study

Skilled team provides advanced surgical interventions

BackPage 1 of 1Next
Advertisement
Ad